Fidelity
Home > Boards > Other Markets > ETFs > ProShares Ultra Silver (AGQ)

Thank goodness for that! Street talk is

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Sunnybank Member Profile
Member Level 
Followed By 82
Posts 6,805
Boards Moderated 3
Alias Born 01/17/11
160x600 placeholder
Johnson & Johnson Earnings Rise 35%
Johnson & Johnson earns $4.73 billion, or $1.64 a share, led by continued sales growth in its pharmaceutical business. Revenue increased 3.5% to $18.12 billion. It also lifted its EPS estimate range for the year.
More Top Equities Stories Of The Day
GM's Barra Unveils Further Plans to Improve Safety
Glencore Xstrata Buys Caracal -- Update
Citi Picks Dewilde to Lead Asia Markets and Investor Services Business
Sales of Johnson s New Hepatitis Drug Soars
Twitter Co-Founders, CEO Won't Sell Shares -- 2nd Update
Columnist Joanna Stern answers readers' technology questions
Surgical Device Maker ConMed Exploring Sale -Reuters
Yahoo Shows Signs of Growth
Sunnybank Member Level  Friday, 04/27/12 08:13:56 AM
Re: Montanore post# 1729
Post # of 1963 
Thank goodness for that! Street talk is that commodities seem to have bottomed, and we never know with the Bernanke what might happen. This puppy swings like a barnyard gate, but the potential payday going forward could be worth the wild ride. Good luck!

You cannot get the water to clear up until you get the pigs out of the creek!
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist